- Nachrichtendetail
-
18.04.2024 14:38:37 - dpa-AFX: *ABBVIE'S PHASE 3 STUDY OF UPADACITINIB SHOWS POSITIVE RESULTS IN GIANT CELL ARTERITIS PATIENTS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
ABBVIE | A1J84E | NYSE | 171,410 | 18.06.24 20:24:26 | +1,730 | +1,02% | 171,420 | 171,480 | 170,440 | 169,680 |
